Berberine alleviates amyloid-beta pathogenesis via activating LKB1/AMPK signaling in the brain of APP/PS1 transgenic mice.

CONCLUSION: BBR alleviates Aβ pathogenesis via enhancing the activation of LKB1/AMPK signaling in the AD transgenic mice. PMID: 30873920 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30873920?dopt=Abstract

Source: Current Molecular Medicine - March 14, 2019 Category: Molecular Biology Authors: Cai ZY, Wang CL, Lu TT, Yang WM Tags: Curr Mol Med Source Type: research